☰ Menu

GFMER members pages / Pages des membres de la FGFRM

Chirurgie réfractive, chirurgie laser de l’oeil / Refractive surgery, eye laser surgery

Bijan Farpour

Bijan Farpour

Docteur en médecine
Spécialiste FMH en ophtalmologie et ophtalmochirurgie


Dr Bijan Farpour
Vision Laser
Place de la Gare 1, 1225 Chêne-Bourg, Suisse  
tél. : +41 22 860 80 60

fax : +41 22 860 80 65

Vision Laser

Titulaire d’une spécialisation en ophtalmologie à l’Hôpital Universitaire de Genève, le Dr Bijan Farpour poursuit pendant trois ans une formation post-graduée en Australie au Save Sight Institute - Sydney Eye Hospital dans le domaine de la cornée et chirurgie réfractive.
À son retour à Genève en 2001, le Dr Farpour est nommé Chef de clinique adjoint à la Clinique d’Ophtalmologie des HUG, avant de s’établir en pratique privée et poursuivre une activité de médecin consultant auprès de cette même Clinique.

Sélection de publications / Selected publications

Farpour B, Browne A, McClellan B, Billson FA. Combined iridocyclectomy and lensectomy surgical technique modified for the removal of an iris cyst in a child. Ophthalmic Surg Lasers 2002 Feb;33(1):62-65.

The purpose of this report is to describe a modified surgical iridocyclectomy technique and lensectomy for the removal of a recurrent iris cyst and a cataract in a child. A 3-year-old boy underwent uncomplicated standard iridocyclectomy for the removal of an enlarging congenital epidermal iris cyst. In the postoperative period, the cyst recurred. A second surgical intervention was performed using a modified iridocyclectomy technique. Sclerocorneal dissection of the involved quadrant was performed. After a lensectomy, an additional deep lamellar dissection of the peripheral cornea was undertaken prior to iris cyst removal and pupil reconstruction. This modified two-layered iridocyclectomy technique permits an elegant access to the iris lesion and allows the construction of a two-layered watertight wound, reducing the risk of hypotony and wound ectasia. We believe it also allows a better control of astigmatism and is a safe procedure in the pediatric population, particularly during the amblyogenic period.

Farpour B, McClellan KA. Diagnosis and management of chronic blepharokeratoconjunctivitis in children. J Pediatr Ophthalmol Strabismus 2001 Aug;38(4):207-212.

PURPOSE: To describe the history, symptoms, and clinical signs and discuss the treatment of blepharokeratoconjunctivitis. METHODS: Eight children (five girls and three boys), ranging in age from 3.5-13 years, were clinically diagnosed with blepharokeratoconjunctivitis. Microbiology studies were performed in four of the eight children. Treatment consisted of lid hygiene, oral erythromycin suspension, and preservative-free steroids. Duration of therapy was directed by clinical improvement. RESULTS: Average age at onset was 3.2 years (range: 0.5-8 years). Lid disease, conjunctival redness, and inferior superficial corneal vascularization were consistent features (100%). Other signs were punctate corneal epithelial staining, inferior subepithelial vascularization and infiltrate, conjunctival phlyctenules, corneal phlyctenules, and circumferential pannus. Microbiology testing demonstrated coagulase-negative staphylococcus and Propionibacterium acnes. Average follow-up was 8.3 months (range: 2-23 months). All patients had relief of symptoms within 2-3 weeks. Clinical signs took more time to regress but all had progressive improvement of the ocular surface by 2 months. Blepharokeratoconjunctivitis reactivated in all patients during follow-up, and repeat therapy was administered. CONCLUSION: Blepharokeratoconjunctivitis in childhood is a chronic inflammatory process that can have different presentations. It can be successfully treated with oral erythromycin and topical steroids.

Présentations en ligne / Online presentations